Displaying 1 - 12 of 54

Display:

12 24 48

General Hepatology

5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View

General Hepatology

5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View

General Hepatology

5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View

General Hepatology

5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View

General Hepatology

5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View

Immune-Mediated and Cholestatic Diseases

4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View

Cirrhosis & Complications

4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View

Cirrhosis & Complications

4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View

Cirrhosis & Complications

4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View

Displaying 1 - 12 of 54

Display:

12 24 48